Nanan Kyster K, Sturgill David M, Prigge Maria F, Thenoz Morgan, Dillman Allissa A, Mandler Mariana D, Oberdoerffer Shalini
Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
iScience. 2019 Sep 27;19:326-339. doi: 10.1016/j.isci.2019.07.041. Epub 2019 Jul 30.
The mechanisms supporting dynamic regulation of CTCF-binding sites remain poorly understood. Here we describe the TET-catalyzed 5-methylcytosine derivative, 5-carboxylcytosine (5caC), as a factor driving new CTCF binding within genomic DNA. Through a combination of in vivo and in vitro approaches, we reveal that 5caC generally strengthens CTCF association with DNA and facilitates binding to suboptimal sequences. Dramatically, profiling of CTCF binding in a cellular model that accumulates genomic 5caC identified ~13,000 new CTCF sites. The new sites were enriched for overlapping 5caC and were marked by an overall reduction in CTCF motif strength. As CTCF has multiple roles in gene expression, these findings have wide-reaching implications and point to induced 5caC as a potential mechanism to achieve differential CTCF binding in cells.
支持CTCF结合位点动态调控的机制仍知之甚少。在此,我们描述了TET催化的5-甲基胞嘧啶衍生物5-羧基胞嘧啶(5caC),它是驱动基因组DNA内新的CTCF结合的一个因素。通过体内和体外方法相结合,我们发现5caC通常会增强CTCF与DNA的结合,并促进其与次优序列的结合。引人注目的是,在一个积累基因组5caC的细胞模型中对CTCF结合进行分析,发现了约13000个新的CTCF位点。这些新位点富含重叠的5caC,并且CTCF基序强度总体降低。由于CTCF在基因表达中具有多种作用,这些发现具有广泛的意义,并指出诱导产生的5caC是在细胞中实现差异性CTCF结合的一种潜在机制。